BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,010,090

« Back to Dashboard

Summary for Patent: 5,010,090

Title: N-(butenyl substituted) azaheterocyclic carboxylic acids
Abstract:1-Aminobut-3-en derivatives having optionally substituted furanyl, thienyl, pyridyl and/or pyrrolyl in the 4-position and 3-carboxypiperidin-1-yl, 3-carboxytetrahydropyrid-1-yl or 3 carboxymethylpyrrolidin-1-yl in the 1-position potentiate GABA-ergic neurotransmission.
Inventor(s): Gronvald; Frederik C. (Vedbaek, DK), Braestrup; Claus (Roskilde, DK)
Assignee: Novo Nordisk A/S. (Bagsvaerd, DK)
Application Number:07/254,557
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,010,090

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Denmark2883/85Jun 26, 1985
DenmarkPCT/DK86/00076Jun 26, 1986

International Patent Family for Patent: 5,010,090

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria67196► Subscribe
Australia599326► Subscribe
Australia6133686► Subscribe
Canada1284503► Subscribe
Germany3681441► Subscribe
Denmark100887► Subscribe
Denmark156398► Subscribe
Denmark288385► Subscribe
European Patent Office0236342► SubscribeSPC/GB98/022United Kingdom► Subscribe
European Patent Office0236342► Subscribe97C0107Belgium► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Cantor Fitzgerald
Daiichi Sankyo
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: